Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice

Environmental and Molecular Mutagenesis

Volumn 31, Issue 3, 1998, Pages 248-256

  Butterworth, Byron E ^a   Templin, Michael V ^a   Constan, Alexander A ^a   Sprankle, Catherine S ^a   Wong, Brian A ^a   Pluta, Linda J ^a   Everitt, Jeffrey I ^a   Recio, Leslie ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Big Blue ; Cell proliferation; Chloroform carcinogenesis; Dimethylnitrosamine; lacI mutagenesis assay; Mutagenesis assay; Mutation induction

Indexed keywords

CHLOROFORM; DIMETHYLNITROSAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; DRUG COMPARISON; FEMALE; LIVER; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; TRANSGENIC MOUSE;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANIMALS; CHLOROFORM; DIMETHYLNITROSAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LAC OPERON; LIVER; LIVER DISEASES; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; MICE; MICE, TRANSGENIC; ORGAN SIZE; PRECANCEROUS CONDITIONS; TRANSGENES;

ANIMALIA; MUS MUSCULUS;

EID: 0031945332     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1998)31:3<248::AID-EM6>3.0.CO;2-G     Document Type: Article

References (39)

1. Ammann P, Kedderis GL (1997): Chloroform-induced DNA double-strand breaks in freshly isolated male B6C3F1 mouse and F-344 rat hepatocytes. Fundam Appl Toxicol 36:223.
2. 2u-globulin nephropathy. Annu Rev Pharmacol Toxicol 30:349-367.
3. Butterworth BE, Slaga, TJ, Farland, W, McClain, M. (eds.) (1991): "Chemically Induced Cell Proliferation: Implications for Risk Assessment." New York: Wiley-Liss.
4. Butterworth BE, Popp JA, Conolly RB, Goldsworthy TL (1992): Chemically-induced cell proliferation in carcinogenesis. In Vainio H, Magee PN, McGregor DB, McMichael AJ (eds): "Mechanisms of Carcinogenesis in Risk Identification." IARC Scientific Publication Number 116, pp 279-305.
5. Butterworth BE, Conolly, RB, Morgan, KT (1995): A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett 93:129-146.
6. 1 mice. Toxicologist 36:135.
7. Cattley RC, Marsman DM, Popp JA (1991): Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator Wy-14,643 in rat liver. Carcinogenesis 12:469-473.
8. Cohen SM, Ellwein LB (1990): Cell proliferation in carcinogenesis. Science 249:1007-1011.
9. Constan AA, Peters JM, Gonzalez FL, Everitt J, Wolf DC, Kedderis GL, Butterworth BE (1997): The role of metabolism in chloroform-induced nephrotoxicity and regenerative cell proliferation. 16th International Symposium for the Society of Toxicologic Pathologists.
10. Craun GF (ed.) (1993): "Safety of Water Disinfection: Balancing Chemical and Microbial Risks." Washington, DC: ILSI Press.
11. 3H)thymidine administered by injection or osmotic pump. Carcinogenesis 11:2245-2251.
12. Elia MC, Storer RD, McKelvey TW, Kraynak AR, Barnum JE, Harmon LS, DeLuca JG, Nichols WW (1994): Rapid DNA degradation in primary rat hepatocytes treated with diverse cytotoxic chemicals. Analysis by pulsed field gel electrophoresis and implications for alkaline elution assays. Environ Mol Mutagen 24:181-191.
13. Gossen JA, Martus HJ, Wei JY, Vijg J (1995): Spontaneous and X-ray induced deletion mutations in a lacZ plasmid based transgenic mouse model. Mutat Res 331:89-97.
14. IPCS (International Programme on Chemical Safety) (1994): Chloroform, Environmental Health Criteria 163. World Health Organization, Geneva.
15. 1 mice. Fundam Appl Toxicol 5:760-769.
16. Larson JL, Sprankle CS, Butterworth BE (1994a): Lack of chloroforminduced DNA repair in vitro and in vivo in hepatocytes of female B6C3F1 mice. Environ Mol Mutagen 23:132-136.
17. Larson JL, Wolf DC, Butterworth BE (1994b): Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vs ad libitum in drinking water. Fundam Appl Toxicol 22:90-102.
18. Larson JL, Wolf DC, Butterworth BE (1994c): Induced cytolethality and regenerative cell proliferation in the livers and kidneys of male B6C3F1 mice given chloroform by gavage. Fundam Appl Toxicol 23:537-543.
19. 1 mice and male F-344 rats. Fundam Appl Toxicol 22:431-446.
20. Larson JL, Templin MV, Wolf DC, Jamison KC, Leininger JR, Méry S, Morgan KT, Wong BA, Conolly RB, Butterworth BE (1996): A 90-day chloroform inhalation study in female and male B6C3F1 mice: Implications for cancer risk assessment. Fundam Appl Toxicol 30:118-137.
21. Mirsalis J (1993): Dosing regimens for transgenic animal mutagenesis assays. Environ Mol Mutagen 21:118-119.
22. Monforte JA, Winegar RA, Rudd CJ (1994): Megabase genomic DNA isolation procedure for use in transgenic mutagenesis assays (Abstract). Environ Mol Mutagen 23(Suppl 23):46.
23. Monticello TM, Swenberg JA, Gross EA, Leininger JR, Kimbell JS, Seilkop S, Starr TB, Gibson JE, Morgan KT (1996): Conrrelation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res 56:1012-1022,
24. Nakajima T, Eloovara E, Okino T, Gelboin HV, Klockars M, Riihimaki V, Aoyama T, Vainio H (1995): Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat. Biochem Pharmacol 133:215-222.
25. NCI (National Cancer Institute) (1976): "Carcinogenesis Bioassay of Chloroform." Bethesda, MD: National Technical Information Service No. PB264018/AS.
26. 2+ in cell killing. Chem Res Toxicol 3:484-494.
27. NIH (National Institutes of Health) (1985): Guide for the care and use of laboratory animals. U.S. Department of Health and Human Services, Public Health Service, NIH Publication No. 86-23.
28. Provost GS, Kretz PL, Hamner RT, Matthews CD, Rogers BJ, Lundberg KS, Dycaico MJ, Short JM (1993): Transgenic systems for in vivo mutation analysis. Mutat Res 288:133-149.
29. 1 lacI transgenic mice exposed to 1,3-butadiene. Environ Mol Mutagen 26:1-8.
30. Rogers BJ, Provost GS, Young RR, Putman DL, Short JM (1995): Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacl transgenic mouse mutagenesis assay (I). Mutat Res 327:57-66.
31. Tao KS, Urlando C, Heddle JA (1995): Comparison of somatic mutation in a transgenic versus host locus. Proc Natl Acad Sci USA 90:10681-10685.
32. Templin MV, Larson JL, Butterworth BE, Jamison KC, Wong BA, Wolf DC (1996a): A 90-day chloroform inhalation study in F-344 rats: Profile of toxicity and relevance to cancer studies. Fundam Appl Toxicol 32:109-125.
33. Templin MV, Jamison KC, Wolf DC, Morgan KT, Butterworth BE (1996b): Comparison of chloroform-induced toxicity in the kidneys, liver, and nasal passages of male Osborne-Mendel and F-344 rats. Cancer Lett 104:71-78.
34. 1 mice. Cancer Lett 108:225-231.
35. Walker VE, Fennell TR, Boucheron JA, Fedtke N, Ciroussel F, Swenberg JA (1990): Macromolecular adducts of ethylene oxide: A literature review and a time-course study on the formation of 7-(2-hydroxyethyl)guanine following exposures of rats by inhalation. Mutat Res 233:151-164.
36. Weisburger JH, Williams GM (1981): Carcinogen testing: Current problems and new approaches. Science 214:401-407.
37. Wong BA, Moss OR (1996): Application of a building management system to automate a 90-day chloroform inhalation study. Toxicol Meth 6:53-64.
38. 1 mice. Proceedings of the Fifty-third Annual Meeting of the Japanese Cancer Association. (See also Matsushima T (1994): An inhalation carcinogenesis study of chloroform. Initial Report. Japan Bioassay Laboratory. Japan Industrial Safety and Health Association, 2445 Ohshibahara Hirasawa Hando Kanagawa, 257 Japan.)
39. 1 mice. Proceedings of the Fifty-third Annual Meeting of the Japanese Cancer Association. (See also Matsushima T (1994): An inhalation carcinogenesis study of chloroform. Initial Report. Japan Bioassay Laboratory. Japan Industrial Safety and Health Association, 2445 Ohshibahara Hirasawa Hando Kanagawa, 257 Japan.)